RHUMBLINE ADVISERS - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 65 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q3 2020. The put-call ratio across all filers is 1.38 and the average weighting 1.2%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q1 2021$104,000
+9.5%
24,4110.0%0.00%
Q4 2020$95,000
+2.2%
24,411
+5.7%
0.00%
Q3 2020$93,000
-17.7%
23,091
-13.2%
0.00%
Q2 2020$113,0000.0%26,596
-0.8%
0.00%
Q1 2020$113,000
+7.6%
26,8170.0%0.00%
Q4 2019$105,000
-55.5%
26,817
+0.2%
0.00%
Q3 2019$236,000
-5.2%
26,769
-0.7%
0.00%
Q2 2019$249,000
+44.8%
26,954
+0.8%
0.00%
Q1 2019$172,000
-33.8%
26,747
-3.1%
0.00%
-100.0%
Q4 2018$260,000
-30.3%
27,594
+48.9%
0.00%0.0%
Q3 2018$373,000
-35.6%
18,530
-6.7%
0.00%0.0%
Q2 2018$579,000
+22.7%
19,855
+25.2%
0.00%0.0%
Q1 2018$472,000
-8.9%
15,860
-1.4%
0.00%0.0%
Q4 2017$518,000
-26.4%
16,090
-20.5%
0.00%
-50.0%
Q3 2017$704,000
+18.1%
20,247
+1.2%
0.00%
+100.0%
Q2 2017$596,000
+21.9%
20,012
+22.1%
0.00%0.0%
Q1 2017$489,000
+88.1%
16,394
+10.5%
0.00%0.0%
Q4 2016$260,000
-21.0%
14,840
+7.4%
0.00%0.0%
Q3 2016$329,000
+50.9%
13,815
+1.6%
0.00%0.0%
Q2 2016$218,000
-27.1%
13,595
-4.9%
0.00%0.0%
Q1 2016$299,000
-16.5%
14,302
+7.8%
0.00%0.0%
Q4 2015$358,000
+27.0%
13,262
+30.7%
0.00%0.0%
Q3 2015$282,000
+19.5%
10,147
+5.5%
0.00%0.0%
Q2 2015$236,0009,6200.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q3 2020
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders